Long-term contraception with the lynestrenol 'mini-pill'.
D000284:Administration, Oral; D000328:Adult; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001835:Body Weight / Q000187:drug effects; D001940:Breast / Q000187:drug effects; D002490:Central Nervous System / Q000187:drug effects; D005260:Female; D005500:Follow-Up Studies; D006261:Headache / Q000139:chemically induced; D006801:Humans; D007989:Libido / Q000187:drug effects; D008099:Liver / Q000187:drug effects; D008234:Lynestrenol / Q000008:administration & dosage / Q000009:adverse effects / Q000494:pharmacology*; D008598:Menstruation / Q000187:drug effects; D008599:Menstruation Disturbances / Q000139:chemically induced; D009325:Nausea / Q000139:chemically induced; D013997:Time Factors
D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D008234:Lynestrenol